1Taylor E, Gomel V. The uterus and fertility. Fertil Steril,2008, 89 : 1-16.
2Nappi L, lndraecolo U, Di Spiezio Sardo A, et al. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps? J Minim Invasive Gynecol,2009,16:157-162.
3Serimin F, Limone A, Wiesenfeld U, et al. Tubercular endometritis visualized as endometrial micropolyps during hysteroscopic procedure. Arch Gynecol Obstet, 2010,281 : 1079- 1080.
4A1-Je~out M, Black K, Schulke L, et al. Novel finding of high density of activated mast cells in endometrial polyps. Fertil Steril, 2009,92 : 1104-1106.
5Erdemoglu E, Gtiney M, Karahan N, et al. i[mmunohistochemical expression of MMP-2, MMP-9 and COX-2 in Stage IA malignant polyps of the endometrium. Eur J Gynaecol 0ncol,2008,29:444- 449.
6Maia H Jr, Correia T, Freitas LA, et al. Cyclooxygenase-2 expression in endometrial polyps during menopause. Gynecol Endocrinol,2005 ,21:336-339.
7Erdemoglu E, Giiney M, Karahan N, et al. Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas,2008 ,59 :268-274.
8Tokyol C, Aktepe F, Dilek FH, et al. Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Patho1,2009,28 : 148-156.
10Maia H Jr, Pimentel K, Silva TM, et al. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrino1,2006,22 : 219-224.
